海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Glucagon Counterregulation in Type 1 Diabetes
- Type 1 Diabetes Mellitus
- United States
- 2018-05-24
Recruiting
- Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
- Chronic Lymphocytic Leukemia;CLL;SLL;Small Lymphocytic Lymphoma
- United States
- 2018-05-21
Recruiting
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
- Ulcerative Colitis
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Romania, Russian Federation, Serbia, Slovakia, Spain, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-05-04
Recruiting
- Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
- Agitation,Psychomotor;Agitation,Psychomotor;Agitation,Psychomotor
- United States
- 2018-04-11
Recruiting
- Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
- Melanoma;Advanced NSCLC;Urothelial Carcinoma;Synovial Sarcoma
- United Kingdom, United States
- 2018-04-05
Recruiting
- In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
- Pancreatic Cancer
- United States
- 2018-04-03
Recruiting
- Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
- Melanoma;Melanoma;Melanoma
- United States
- 2018-03-16
Not recruiting
- A 4-Day Study to Evaluate Phototoxicity of CCP-020 (Diacerein 1%) in Healthy Subjects
- Healthy
- United States
- 2018-03-05
Not recruiting
- Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
- Hidradenitis Suppurativa (HS)
- Bulgaria, Canada, Denmark, France, Germany, Greece, Netherlands, Poland, United States
- 2018-02-27
Authorised
- Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1)
- Ulcerative Colitis MedDRA version: 20.1 Level: LLT Classification code 10045365 Term: Ulcerative colitis System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Belgium, Czech Republic, Germany, Netherlands, Poland, Russian Federation, Serbia, Slovakia, Spain, Ukraine, United Kingdom, United States
- 2018-02-20
Recruiting
- A Phase 1 Dose-escalation Study of FF 10832 for the Treatment of Advanced Solid Tumors
- Advanced Solid Tumors
- United States
- 2018-02-09
Recruiting
- Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
- Advanced Solid Tumors;Pancreatic Cancer;Non Small Cell Lung Cancer;Ovarian Cancer
- Canada, Spain, United States
- 2018-02-07
Recruiting
- Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
- Advanced Malignancies
- United States
- 2018-02-05
Not recruiting
- Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
- Zika Virus;Zika Virus Infection
- United States
- 2018-01-23
Not recruiting
- Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
- Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus
- United States
- 2008-04-14
Not recruiting
- Genetics of Polycystic Ovary Syndrome
- PCOS
- United States
- 2008-03-26
Recruiting
- Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
- Viral Pneumonia;Bacterial Pneumonia
- United States
- 2008-03-24
Not recruiting
- Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine
- Parainfluenza;Virus Diseases
- United States
- 2008-03-05
Not recruiting
- A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
- Liver Disease
- United States
- 2008-02-12
Not recruiting
- Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94
- Rheumatoid Arthritis
- Canada, United States
- 2008-02-05